These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30265415)

  • 1. The role of interleukins in preeclampsia: A comprehensive review.
    Bellos I; Karageorgiou V; Kapnias D; Karamanli KE; Siristatidis C
    Am J Reprod Immunol; 2018 Dec; 80(6):e13055. PubMed ID: 30265415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22: biomarker of maternal and fetal inflammation?
    Bersani I; De Carolis MP; Foell D; Weinhage T; Rossi ED; De Carolis S; Rubortone SA; Romagnoli C; Speer CP
    Immunol Res; 2015 Feb; 61(1-2):4-10. PubMed ID: 25407645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher decidual EBI3 and HLA-G mRNA expression in preeclampsia: Cause or consequence of preeclampsia.
    Prins JR; van der Hoorn MLP; Keijser R; Ris-Stalpers C; van Beelen E; Afink GB; Claas FHJ; van der Post JAM; Scherjon SA
    Hum Immunol; 2016 Jan; 77(1):68-70. PubMed ID: 26472010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying immune mechanisms mediating the hypertension during preeclampsia.
    LaMarca B; Cornelius DC; Harmon AC; Amaral LM; Cunningham MW; Faulkner JL; Wallace K
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R1-9. PubMed ID: 27097659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA-G extended haplotypes and one HLA-E polymorphism in a large-scale study of mother-child dyads with and without severe preeclampsia and eclampsia.
    Nilsson LL; Djurisic S; Andersen AM; Melbye M; Bjerre D; Ferrero-Miliani L; Hackmon R; Geraghty DE; Hviid TV
    HLA; 2016 Oct; 88(4):172-86. PubMed ID: 27596021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunogenetic Conundrum of Preeclampsia.
    Lokki AI; Heikkinen-Eloranta JK; Laivuori H
    Front Immunol; 2018; 9():2630. PubMed ID: 30483272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in Inflammatory Mediator Genes and Risk of Preeclampsia in Taiyuan, China.
    Wu W; Yang H; Feng Y; Zhang P; Li S; Wang X; Peng T; Wang F; Xie B; Guo P; Li M; Wang Y; Zhao N; Wang S; Zhang Y
    Reprod Sci; 2017 Apr; 24(4):539-547. PubMed ID: 27481922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.
    Cubro H; Kashyap S; Nath MC; Ackerman AW; Garovic VD
    Curr Hypertens Rep; 2018 Apr; 20(4):36. PubMed ID: 29713810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of female fetal sex on preeclampsia and the maternal immune milieu.
    Taylor BD; Ness RB; Klebanoff MA; Tang G; Roberts JM; Hougaard DM; Skogstrand K; Haggerty CL
    Pregnancy Hypertens; 2018 Apr; 12():53-57. PubMed ID: 29674199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes and the preeclampsia syndrome.
    Mütze S; Rudnik-Schöneborn S; Zerres K; Rath W
    J Perinat Med; 2008; 36(1):38-58. PubMed ID: 18184097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First and second trimester immune biomarkers in preeclamptic and normotensive women.
    Taylor BD; Ness RB; Klebanoff MA; Zoh R; Bass D; Hougaard DM; Skogstrand K; Haggerty CL
    Pregnancy Hypertens; 2016 Oct; 6(4):388-393. PubMed ID: 27939488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental cytokines and preeclampsia.
    Keelan JA; Mitchell MD
    Front Biosci; 2007 Jan; 12():2706-27. PubMed ID: 17127274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.
    Procopciuc LM; Caracostea G; Zaharie G; Stamatian F
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1754-60. PubMed ID: 25007988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A leading role for the immune system in the pathophysiology of preeclampsia.
    Laresgoiti-Servitje E
    J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein profiling of preeclampsia placental tissues.
    Shu C; Liu Z; Cui L; Wei C; Wang S; Tang JJ; Cui M; Lian G; Li W; Liu X; Xu H; Jiang J; Lee P; Zhang DY; He J; Ye F
    PLoS One; 2014; 9(11):e112890. PubMed ID: 25392996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of preeclampsia: the genetic component.
    Valenzuela FJ; Pérez-Sepúlveda A; Torres MJ; Correa P; Repetto GM; Illanes SE
    J Pregnancy; 2012; 2012():632732. PubMed ID: 22175024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.